Publications by authors named "Isabel Muniz"

Claim this Profile
M
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in a patient with lung adenocarcinoma.
Sena Valcárcel, Isabel Muñiz

Med Clin (Barc)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Brain Stimulation of the Nucleus Accumbens, Ventral Striatum, or Internal Capsule Targets for Medication-Resistant Obsessive-Compulsive Disorder: A Multicenter Study.
Cristina V Torres Díaz, Svenja Treu, Bryan Strange, Monica Lara, Marta Navas

World Neurosurg· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of topotecan given intravenously for 5 days every three weeks in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes: a phase II study.
Emilio Esteban Gonzalez, Noemi Villanueva, Joaquin Fra, Jose Pablo Berros, Paula Jimenez

Invest New Drugs· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study.
Emilio Esteban, Noemi Villanueva, Isabel Muñiz, Yolanda Fernández, Joaquin Fra

Invest New Drugs· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): results of a prospective randomized study.
Emilio Esteban, Jose-Luis de Sande, Noemi Villanueva, Norberto Corral, Isabel Muñiz

Lung Cancer· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: results of a prospective randomized phase II study.
Emilio Esteban, Joaquin Fra, Yolanda Fernández, Norberto Corral, José M Vieitez

Invest New Drugs· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of carboplatin in patients with advanced non-small cell lung cancer pre-treated with a non-platinum combination.
Emilio Esteban-Gonzalez, Yolanda Fernández, Noemí Villanueva, Joaquin Fra, Isabel Muñiz

Invest New Drugs· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes.
Rosa Sánchez, Emilio Esteban, Isabel Palacio, Yolanda Fernández, Isabel Muñiz

Invest New Drugs· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: a dose-finding study.
Emilio Esteban, Antonio Modollel, Luis González de Sande, Isabel Palacio, Isabel Muñiz

Breast Cancer Res Treat· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irinotecan in the treatment of advanced colorectal cancer in patients pretreated with Fluorouracil-based chemotherapy: a study to determine recommendable therapeutic dosage.
Jose M Viéitez, Juan Carrasco, Emilio Esteban, Joaquín Fra, Elena Alvarez

Am J Clin Oncol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis